Work

Supplementary Figure 2A from Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 2a: Kaplan-Meier Survival Estimates: Interim Overall Survival. (A) Intent-to-treat population, n=701.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361920594
Cites:
Cited by:
Related to: 10